David Brennan
‘Golden parachute’ for AZ’s David Brennan
July 17, 2012Sales and Marketing AstraZeneca, David Brennan, GMB
David Brennan, the former chief executive of AstraZeneca, could receive more than £4million as a payout after being ousted from …
Brennan bows to pressure and quits AstraZeneca
April 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, David Brennan, Q1, pharma
AstraZeneca’s chief executive David Brennan is to step down from his post following mounting dissatisfaction with his leadership. Brennan, who …
Investors ramp up pressure on AZ chief
April 10, 2012Sales and Marketing AstraZeneca, David Brennan
AstraZeneca’s chief executive David Brennan is coming under increasing pressure from investors, and his future at the firm could be …
AstraZeneca to cut 7,300 jobs as growth stalls
February 2, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, David Brennan, R&D
AstraZeneca will make 7,300 cuts to its sales and R&D staff by 2014, but the company has not yet said …
Latest content
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
